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Recent evidence suggests that postischemic contractile dys- 
function of viable myocardium salvaged by reperfusion 
(“stunned myocardium”) may be a consequence of abnor- 
mal calcium flux within the previously ischemic cells. 
Calcium channel blocking agents have been shown to 
enhance contractile function of stunned postischemic tissue, 
but it is not certain whether these improvements in function 
are due to the profound hemodynamic and vasodilator 
effects of these agents or to a direct effect on calcium flux 
within the stunned myocytes. Therefore, the effects of 1) 
high doses of nifedipine, given intravenously at 30 min after 
reperfusion, and 2) minute doses of nifedipine, infused 
directly into the coronary circulation at 30 min after reflow, 
were assessed and compared in anesthetized open chest 
dogs subjected to 15 min of transient coronary artery 
occlusion. 
As anticipated, intravenous nifedipine significantly re- 
duced arterial pressure and increased regional myocardial 
blood flow. In addition, intravenous nifedipine restored 
systolic contractile function of the stunned, previously 
ischemic tissue to essentially normal preocclusion values: 
segment shortening averaged 102 + 8% versus 26 f 11% of 
baseline at 2 h after treatment in treated versus control 
dogs, respectively (p < 0.003). Low dose intracoronary 
infusion of nifedipine did not alter hemodynamic variables 
or myocardial blood flow, but did improve segment short- 
ening (90 f 9% versus 37 f 10% of preocclusion values at 
1 h after treatment versus 25 min after reperfusion [that is, 
pretreatment], respectively; p < 0.03). 
These data indicate that the calcium channel blocking 
agent nifedipine, given 30 min after reperfusion, enhances 
systolic contractile function of postischemic stunned myo- 
cardium. Because these improvements in function could be 
obtained even in the absence of systemic hemodynamic or 
coronary vasodilator effects, the data suggest that nifedi- 
pine may act by favorably modulating calcium flux within 
the stunned myocytes. 
(J Am Co11 Cardiol1989;13:1176-83) 
A brief (< 15 min) period of transient coronary artery occlu- 
sion does not result in myocyte necrosis (l), yet the contrac- 
tile function of this viable myocardium salvaged by reperfu- 
sion remains depressed or “stunned” for hours to days after 
reflow (2-5). This phenomenon of the stunned myocardium, 
first characterized in experimental models of transient coro- 
nary artery occlusion (2-5), has more recently been identi- 
fied in patients after successful reperfusion for the treatment 
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of evolving myocardial infarction, in instances of unstable 
angina and after exercise-induced ischemia in patients with 
multivessel coronary artery disease (6). 
Recent evidence (7-11) suggests that altered calcium 
flux-either during occlusion or at the time of reperfusion- 
may play an important role in the pathophysiology of 
stunned myocardium. Indirect support for this theory was 
obtained from two in vivo studies (12,13) that demonstrated 
that treatment with the calcium channel blocking agents 
verapamil (12) and diltiazem (13) significantly enhanced 
regional contractile function of stunned, previously ischemic 
tissue. Interpretation of these results is complicated, how- 
ever, by the profound and well documented hemodynamic 
and vasodilator effects of these agents (12,14,15); that is, it is 
not certain whether the beneficial effects of calcium channel 
blocking agents are due to a direct effect on the stunned 
myocytes or are merely a consequence of their concomitant 
reduction in afterload or increased coronary flow, or both. 
To attempt to resolve this issue, we used an anesthetized, 
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open chest canine model to assess and compare the effects of 
1) high doses of the calcium channel blocking agent nifedi- 
pine, given intravenously at 30 min after reperfusion, and 2) 
low doses of nifedipine, infused directly into the coronary 
circulation at 30 min after reperfusion (that is, such that no 
peripheral hemodynamic effects or changes in myocardial 
blood flow were observed) on regional contractile function of 
postischemic stunned myocardium. 
Methods 
These studies involving experimental animals conform to 
the Positions of the American Heart Association on Re- 
search Animal Use adopted November 11, 1984 by the 
American Heart Association. 
Protocol I: Intravenous Nifedipine Study 
Experimental preparation. Sixteen mongrel dogs of ei- 
ther gender, weighing an average of 23 t 6 kg, were 
anesthetized with sodium pentobarbital (30 mg/kg body 
weight intravenously), intubated and ventilated with room 
air. Cannulas were placed in the left jugular vein for admin- 
istration of drugs and fluids and in the left common carotid 
artery for measurement of heart rate and arterial pressures. 
A left thoracotomy was performed through the fifth intercos- 
tal space, the ribs were retracted and the heart was exposed 
and suspended in a pericardial cradle. The left atria1 append- 
age was then cannulated for later injection of radioactive 
microspheres for measurement of regional myocardial blood 
flow, and a Millar microtipped pressure transducer was 
positioned within the left ventricular cavity through the left 
atria1 appendage for measurement of left ventricular pres- 
sure and its first derivative (dP/dt). A small segment of the 
left anterior descending coronary artery was dissected free 
of surrounding tissue and isolated, usually just distal to its 
first major diagonal branch. The artery was then briefly 
occluded for <5 s to delineate the extent of cyanosis. 
Hemodynamic and contractile function measurements. 
Regional contractile function in both the soon to be ischemic 
tissue and normally perfused myocardium was assessed by 
sonomicrometry (4,5,12). One pair of ultrasonic crystals, 
used to monitor segment length, was inserted by means of 
small scalpel incisions into the mid-myocardium in the 
center of the left anterior descending coronary artery bed 
and oriented parallel to the minor axis of the heart. A second 
pair of crystals was similarly positioned within the normally 
perfused circumflex artery bed, at a site remote from the 
margin of the soon to be ischemic tissue. Regional contrac- 
tile function in both ischemic and normally perfused myo- 
cardium, arterial and left ventricular pressures and dP/dt 
were monitored continuously throughout the experiment on 
a Gould recorder. 
Randomization and treatment. After initial baseline mea- 
surements of regional contractile function and hemodynamic 
variables, each dog received a bolus injection of lidocaine 
(1.5 mgikg intravenously). The left anterior descending cor- 
onary artery was then abruptly occluded with use of atrau- 
matic vascular clamps. Hemodynamic variables and func- 
tion were assessed at 5 min after occlusion; regional 
myocardial blood flow was measured by injection of radio- 
active microspheres at 10 min after occlusion. Fifteen min- 
utes after occlusion, a supplemental dose of lidocaine was 
administered (0.75 mgikg), and the occluded artery was 
reperfused by removal of the vascular clamps. Hemody- 
namic variables and function were again assessed at 10 and 
25 min after reperfusion. 
At 30 min after reperfision, each dog was randomized in 
a blinded fashion to receive either 1) nifedipine, 0.5 mglkg 
dissolved in a solution of ethanol. ethylene glycol and 
distilled water and infused through the jugular vein at a rate 
of 1 mlimin for approximately 30 min, or 2) solvent alone at 
a rate of 1 mlimin for 30 min. This dose of nifedipine was 
chosen on the basis of pilot experiments performed in our 
laboratory (16), in which we observed that sublingual nife- 
dipine at this approximate dose effectively enhanced re- 
gional contractile function of postischemic stunned myocar- 
dium. Because of the photosensitive nature of nifedipine, 
care was taken to shield all solutions, syringes and cannulas 
throughout preparation and infusion in all dogs. Hemody- 
namic variables and function were monitored at frequent 
intervals throughout treatment, and a second measurement 
of regional myocardial blood flow was made at 2 h after 
treatment. 
At 4 h after treatment (that is, 4.5 h after reperfusion), the 
left anterior descending coronary artery was reoccluded and 
monastral blue pigment injected into the coronary vascula- 
ture through the left atrium to delineate the in vivo area at 
risk. The heart was then arrested by intracardiac injection of 
potassium chloride (20 to 40 mEq) and excised. The posi- 
tions of the crystals were marked and the heart fixed by 
immersion in 10% neutral buffered formalin. 
Protocol II: Intracoronary Ngedipine Study 
In a separate series of experiments, an additional 15 dogs 
(mean weight 25 i 5 kg) were anesthetized and instrumented 
as described for protocol I. In these dogs, however, regional 
contractile function was assessed only in the soon to be 
ischemic myocardium. All dogs received lidocaine and un- 
derwent 15 min of left anterior descending coronary artery 
occlusion. Hemodynamic variables and function were mon- 
itored as described for protocol I; regional myocardial blood 
flow in this second protocol was measured both during 
occlusion and at 25 min after reperfusion. 
Intracoronary dose of nifedipine infusion. At 30 min after 
wperfusion. a small proximal side branch of the left anterior 
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descending coronary artery was cannulated retrogradely 
with use of a 22 gauge (0.8 mm) catheter. Minute doses of 
nifedipine (1.11 to 2.78 x 10e4 mg/kg per min) were then 
infused directly into the previously ischemic myocardium. 
The dose of nifedipine in each dog was titrated such that no 
apparent systemic hemodynamic effects of the drug were 
observed, and the infusion was maintained for 2 h. (In 
preliminary experiments, we found that even slightly higher 
doses of intracoronary nifedipine-on the order of 4 to 4.5 x 
lop4 mg/kg per min-resulted in marked vasodilation and 
reduced mean arterial pressure.) Hemodynamic variables 
and function were monitored at frequent intervals through- 
out treatment; a third measurement of regional myocardial 
blood flow was made at 1 h after infusion. After 2 hours of 
treatment, the dogs were killed as in protocol I. 
Analysis of Data 
Area at risk. After fixation, all hearts were cut into five to 
seven transverse slices, parallel to the atrioventricular 
groove, each approximately 5 mm thick. Correct placement 
of the ultrasonic crystals (that is, in the mid-myocardium, 
well within the center of the previously ischemic or normally 
perfused regions) was confirmed at this time. Epicardial and 
endocardial contours of the basal surfaces of the heart slices 
and the margins of the area at risk were traced onto acetate 
sheets. After right ventricular tissue had been trimmed off, 
the heart slices were weighed. Extent of the area at risk in 
each heart slice was quantified by computed planimetry and 
corrected for the weight of the tissue slice. Total weight of 
the area at risk was then calculated for each heart and 
expressed as a percent of the total left ventricular weight. 
Regional myocardial flow. For measurement of regional 
myocardial blood flow, tissue from both the center of the 
previously ischemic left anterior descending coronary artery 
bed and remote normally perfused myocardium was cut and 
subdivided into endocardial, mid-myocardial and epicardial 
segments. Blood flow was then calculated by the method of 
Domenech et al. (17). 
Hemodynamics. Heart rate, mean arterial pressure, peak 
systolic left ventricular pressure and dP/dt were measured 
and averaged over five continuous cardiac cycles for each 
sample period. In addition, left ventricular end-diastolic 
pressure, measured at the onset of the rapid rise of dP/dt, 
was measured from three cardiac cycles per sample period. 
Segment shortening. By convention (4,5,12), dP/dt was 
also used to define the segment length or separation between 
the ultrasonic crystals during the cardiac cycle; end-diastolic 
lengths were measured at the onset of the rapid rise of dP/dt, 
whereas end-systolic lengths were measured at peak nega- 
tive dP/dt (4,5,12). End-diastolic and end-systolic length 
measurements from both pairs of crystals were obtained 
from three well separated cardiac cycles in each sample 
period, averaged and used to compute segment shortening, 
an index of regional systolic contractile function defined 
(4,5,12) as follows: 
Segment shortening = 
mean end-diastolic length - mean end-systolic length x loo%. 
mean end-diastolic length 
Values of segment shortening measured in the left anterior 
descending coronary artery bed during each sample period 
were normalized and expressed as a percent of their baseline 
value measured before coronary artery occlusion. Values of 
segment shortening measured in the normally perfused cir- 
cumflex artery bed were similarly normalized and expressed 
as a percent of their respective baseline values. 
Statistics. Dogs with high collateral blood flow during 
coronary occlusion and a small area at risk were excluded 
from the final analysis. Specifically, our exclusion criteria, 
established before the onset of the protocols, were as 
follows: values of regional myocardial blood flow in the 
“ischemic” endocardium ~0.25 ml/min per g tissue during 
coronary artery occlusion, area at risk <lo% of the left 
ventricle, or both. No attempt was made to resuscitate dogs 
that died from ventricular fibrillation during occlusion or at 
the time of reperfusion. 
In Protocol I, t tests for unpaired data were used to 
compare area at risk and regional myocardial blood flow 
between the control and intravenous nifedipine-treated 
groups (18). Unpaired t tests were also used to compare 
hemodynamic variables before occlusion, during coronary 
occlusion, at 25 min after reperfusion (that is, before treat- 
ment) and at 30, 120 and 240 min after treatment, and values 
of percent segment shortening during occlusion, at 25 min 
after reperfusion and at 30, 120 and 240 min after treatment. 
Bonferroni’s correction for multiple comparisons (18) was 
then applied to the p values. 
In Protocol II, each dog served as its own control. Thus, 
t tests for paired data were used to compare the measured 
variables before treatment (that is, when stunned, at 25 min 
after reperfusion) versus after treatment in this phase of the 
study. Specifically, regional myocardial blood flow was 
compared at 25 min after reperfusion versus 60 min after 
treatment. Hemodynamic variables and segment shortening 
were compared with use of paired t tests at 5,60 and 120 min 
after infusion versus 25 min after reperfusion. Bonferroni’s 
correction for multiple comparisons (18) was then applied. 
All values are expressed as mean ? SEM, and values are 
considered to differ significantly if p < 0.05. 
Results 
Protocol I: Intravenous Nifedipine 
Of the 16 dogs entered into protocol I, 3 died before 
randomization. Specifically, two of the three dogs died 
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Table 1. Hemodvnamic Variables: Intravenous Nifedipine Protocol 
Reperfusion Treatment 
Treat 
Pre Occlusion 25 Min t 30 Min 120 Min 240 Min 
Heart rate (beatsimin) 
Control 150 + 6 148 ? 6 143 t 5 147 rt 6 159 t 8 169 ? 6 
Nifedipine 156 ? 4 15s -c 4 150 % 6 147 ? 6 167 2 5 182 + 4 
Mean arterial pressure (mm Hg) 
Control 112 r 4 II: + 6 116 + 8 120 ir 7 122 ? 6 125 ? 6 
Nifedipine 112 + 5 112 + 4 I19 + 5 67 ? 4: 84 + 3’ 95 lr 3% 
Left ventricular peak systolic pressure (mm Hg) 
Control 104 + 4 104 ? 6 108 + 8 110 + 6 114 + 6 116? 5 
Nifedipine 108 + 6 107 2 4 II5 II 6 79 + 7* 103 + 5 108 2 8 
Left ventricular end-dlastolic pressure (mm Hg) 
Control 7?2 10 ? 2 x+-2 721 822 721 
Nifedipine 621 IO ? 2 Sk? 921 7* I 721 
Peak positive dP/dt (mm Hgis) 
Control 1.421 t 68 1.304 2 55 1.350 + 100 1,413 ? 92 1,508 ? 87 1.667 + 59 
Nifedioine 1.471 2 76 1.363 ? 91 1.392 + 116 967 ? 160 1.808 + 142 I.904 ? 235 
*p < 0.03: tp < 0 003 vs. control. Pre = before occlusion 
because of ventricular fibrillation during coronary artery 
occlusion whereas one dog developed fibrillation within 
seconds of reperfusion. One additional dog that had been 
randomized to receive nifedipine was excluded from anal- 
ysis because of high collateral blood flow and a small 
area at risk. Thus, a total of 12 dogs (6 control dogs and 6 
treated with intravenous nifedipine) were included in the 
final analysis. 
Area at risk. Area at risk averaged 17.2 t 1.1% and 17.6 
+ 2.0% of the left ventricle in control and nifedipine-treated 
dogs, respectively (p = NS). Thus, intravenous nifedipine 
had no significant effect on area at risk in this model. 
Hemodynamic effects (Table 1). Baseline values of all 
hemodynamic variables measured before coronary artery 
occlusion were comparable between the two treatment 
groups, and remained comparable both during occlusion and 
in the initial 30 min of reperfusion. Infusion of nifedi-pine 
had no significant effect on heart rate, left ventricular end- 
diastolic pressure or dP/dt, and produced only a transient 
reduction in left ventricular peak systolic pressure. As 
anticipated, however, intravenous infusion of nifedipine 
markedly reduced mean arterial pressure throughout the 4 h 
after treatment; for example, at 2 h after treatment was 
initiated, mean arterial pressure averaged 122 t 6 versus 84 
? 3 mm Hg in control dogs versus dogs that received 
nifedipine (p < 0.003 versus control group). 
Regional myocardial blood Row (Table 2). In both groups 
of dogs, the left anterior descending coronary artery bed was 
equally and severely ischemic during coronary artery occlu- 
sion: mean collateral blood flow to the ischemic endocar- 
dium was 0.06 t 0.03 versus 0.05 t 0.02 mlimin per g tissue, 
respectively, in control dogs versus those later randomized 
to receive nifedipine (p = NS). 
At 2 /I mfter treatment, mean values of regional myocar- 
dial blood flow in the previously ischemic left anterior 
descending coronary artery bed of control dogs ranged from 
0.7 to 1.0 mllmin per g tissue. In contrast, intravenous 
infusion of nifedipine essentially doubled blood flow during 
reperfusion: values of regional myocardial blood flow aver- 
aged 2.2 to 2.8 ml/min per g tissue in the nifedipine-treated 
group (p < 0.005). This significant increase in postischemic 
myocardial blood flow associated with nifedipine treatment 
was observed in both the previously ischemic and normally 
perfused regions of the heart. 
Table 2. Regional Myocardial Blood Flow (mlimin per g tissue): Intravenous Nifedipine Protocol 
10 Min Postocclusion 120 Min Posttreatment 
Endo Mid EPI Endo Mid Epi 
lschemic left anterior descending coronary artery bed 
Control 0.06 + 0.03 0.06 2 0.01 0.15 ? 0.06 0.67 ? 0.08 0.91 ? 0.07 1.04 ? 0.13 
Nifedipine 0.05 2 0.02 0.08 z 0.03 0.18 5 0.04 2.15 + 0.45t 2.36 ? 0.27t 2.78 + 0.45: 
Normally perfused circumflex bed 
Control 1.31 ? 0.13 1.23 2 0.09 0.97 + 0.1 I 1.22 ? 0.11 1.33 + 0.11 1.11 + 0.11 
Nifedipine 1.20 + 0.11 1.10 + 0.08 1.01 i- 0.14 1.97 ? 0.38* 2.60 t 0.38t 2.87 c 0.53: 
*p < 0.05; tp < 0.005 vs. control. Endo = endocardium: Epi = epicardium; Mid = mid-myocardlum. 
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Table 3. Segment Shortening (% of preocclusion values) in Nonischemic 
Myocardium: Intravenous Nifedipine Protocol 
Control 
Nifedipine 
Pre 
100% 
100% 
Reperfusion Treatment 
Treat 
Occlusion 25 Min + 30 Min 120 Min 240 Min 
116 k 9% 116 k 8% 106 + 8% 103 2 4% 101 ? 5% 
1142 11% 106 c 11% 116 ? 17% 135 ? 20% IO5 ? 8% 
Pre = before occlusion. 
Segment shortening (Table 3, Fig. 1). In both groups of 
dogs, the myocardium was equally dyskinetic during coro- 
nary artery occlusion and equally stunned before random- 
ization and treatment (Fig. 1). In control dogs, segment 
shortening in the previously ischemic tissue remained de- 
pressed at approximately 20 to 25% of baseline values after 
infusion of vehicle. In contrast, postischemic contractile 
dysfunction was completely ablated in dogs that received 
intravenous nifedipine: segment shortening recovered to 
essentially normal values after the onset of treatment, and 
averaged 89 ? 13% of baseline at the end of the protocol (p 
< 0.03 versus control group; Fig. 1). These data indicate that 
nifedipine administered 30 min after reperfusion significantly 
enhanced systolic contractile function of the stunned post- 
ischemic tissue. 
Segment shortening in remote nonischemic myocardium 
perfused by the circumflex artery bed remained at-or 
slightly above-100% of preocclusion values throughout the 
protocol, and did not differ significantly between the two 
groups either during coronary artery occlusion, during the 
initial 30 min of reperfusion or after treatment (Table 3). 
Protocol II: Intracoronary Nifedipine 
Of the 15 dogs entered into protocol II, 4 died of ventric- 
ular fibrillation during coronary artery occlusion and an 
Figure 1. Segment shortening in the left anterior descending artery 
bed expressed as a percent of preocclusion values (% of PRE) for 
dogs randomized to receive intravenous (I.V.) nifedipine or vehicle. 
*p < 0.03; **p < 0.003 versus corresponding control values; 
Posttreat = after treatment. 
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additional two dogs developed fibrillation at the time of 
reperfusion. Two dogs were excluded from the final analysis 
because their myocardium was not sufficiently ischemic 
during coronary occlusion (as defined in our prospective 
exclusion criteria), and one animal was eliminated because 
of technical problems with the intracoronary infusion. Thus, 
a total of six dogs successfully completed protocol II. 
Area at risk. In dogs receiving intracoronary nifedipine, 
the mean area at risk (17.2 f 2.3% of the left ventricle) was 
similar to that observed in both treated and control dogs in 
the intravenous nifedipine protocol. 
Hemodynamic effects (Table 4). In contrast to the results 
obtained in protocol I, low doses of intracoronary nifedipine 
did not produce significant alterations in any measured 
hemodynamic variable. Specifically, mean arterial pressure 
remained unchanged throughout the protocol, averaging 
119 + 8 mm Hg at 25 min after reperfusion (that is, 
immediately before infusion) and 115 ? 7 mm Hg after 1 h of 
treatment (p = NS). 
Regional myocardial blood flow (Table 5). All dogs exhib- 
ited severe ischemia during coronary artery occlusion. 
Blood flow to the ischemic endocardium averaged 0.07 ? 
0.03 ml/min per g tissue, which was similar to values 
observed in both treated and control dogs in protocol I. In 
contrast to the data obtained in the intravenous study, low 
doses of intracoronary nifedipine did not produce significant 
increases in myocardial blood flow. For example, mean 
regional myocardial blood flow to the previously ischemic 
endocardium was 0.69 5 0.16 mllmin per g tissue at 25 min 
after reperfusion (that is, pretreatment) and 0.65 2 0.09 ml/ 
min per g tissue at I h after infusion (p = NS). Blood flow 
was comparable before and after treatment in all three layers 
of both the previously ischemic and normally perfused 
myocardium. 
Segment shortening (Fig. 2). In all dogs, the myocardium 
was dyskinetic during coronary artery occlusion and stunned 
during the initial 30 min of reflow; at 25 min after reperfu- 
sion, segment shortening averaged only 37 ? 10% of baseline 
preocclusion values. 
Although intracoronary infusion of nifedipine had no 
significant effect on systemic hemodynamic variables or 
regional myocardial blood flow, it did produce an immediate 
and significant improvement in regional contractile function. 
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Table 4. Hemodynamic Variables: Intracoronary Nifedipine Protocol 
Reperfusion 
Treat 
Treatment 
Pre Occlusion 25 Min 1 5 Min 30 Mm 60 Min 120 Min 
Heart rate (beatsimin) 146 t 8 144 + 7 117 i- 5 I45 t 8 I48 + IO I41 % 9 150 t IO 
Mean arterial (mm Hg) pressure 122 + 8 121 ?9 119 -t 8 II6 2 7 121 + 8 II5 + 1 II3 ? 6 
Left ventricular peak systolic pressure (mm Hg) I14 t 8 114 2 9 120 2 9 II7 i 5 I20 ? 6 120 ? 7 112 + 6 
Left ventricular end diastolic pressure (mm Hg) 721 12 t 2 9?2 822 922 852 723 
Peak positive dP/dt (mm Hgis) 1.573 + 127 1.433 t 129 1,437 ? Xl I.566 t 95 1.657 ? I31 1.585 % 92 1.644 t 92 
Pre = before occlusion 
By 5 min after infusion, segment shortening had been 
restored to 7.5 ? 8% of normal (p < 0.03 versus 25 min after 
reperfusion), and was maintained at 80% to 90% of normal 
preocclusion values throughout the 2 h of intracoronary 
infusion. 
Discussion 
Effect of nifedipine on “stunned” myocardium. This 
study demonstrates that the calcium channel blocking agent 
nifedipine given 30 min after reperfusion enhances systolic 
contractile function of postischemic stunned myocardium. 
In fact, segment shortening of the stunned, previously isch- 
emit tissue was restored to normal preocclusion values 
during the initial 4 h after treatment in dogs that received 
intravenous nifedipine. Because significant improvements in 
function were obtained even in the absence of systemic 
hemodynamic effects or coronary vasodilation, data from 
the intracoronary phase of this study suggest that nifedipine 
may exert a direct beneficial effect on the stunned, previ- 
ously ischemic myocytes. 
Our results obtained with intravenous infusion of nifedi- 
pine are in general agreement with previous data obtained in 
in vitro models of postischemic contractile dysfunction. 
Pretreatment with nifedipine significantly enhanced postisch- 
emit recovery of mechanical activity and mitochondrial 
function in isolated perfused hearts subjected to transient 
global ischemia (19-21). Furthermore, Higgins and Black- 
burn (19) found that nifedipine given at the time of reflow 
was virtually as effective in restoring function as was nife- 
dipine given before ischemia in the isolated working rat heart 
model of stunned myocardium. 
Similar salutary results have been documented in the in 
vivo canine model of transient coronary occlusion with use 
of other calcium channel blocking agents. Pretreatment with 
verapamil (12) and diltiazem (13) essentially ablated the 
phenomenon of stunned myocardium. In contrast, however, 
Lamping and Gross (22) reported that intravenous nifedipine 
infused before and during 15 min of coronary artery occlu- 
sion produced only a modest improvement in regional con- 
tractile function after reperfusion (that is, to a steady state 
value of approximately 25% of baseline preocclusion val- 
ues). The apparent discrepancy between our current results 
and those of Lamping and Gross can probably be attributed 
to the considerable differences in both the dose and timing of 
nifedipine treatment: 3 pg/kg bolus + 1 pgikg per min given 
before and during occlusion (22) versus 5 mgikg at 30 min 
after reperfusion used in our study. 
Potential mechanism or mechanisms of action of nifedipine. 
Although calcium channel blocking agents in general (12, 
13)-and nifedipine in particular-clearly enhance recovery 
of function of postischemic tissue, their precise mechanism 
or mechanisms of action on the stunned myocytes have, to 
date, not been defined. There is no question that administra- 
tion of calcium channel blocking agents is associated with 
potent systemic hemodynamic and coronary vasodilator 
Table 5. Regional Myocardial Blood Flow (mlimin per g tissue): Intracoronary Nifedipine Protocol 
Endo Mid Epi 
lschemic left anterior descending coronary artery bed 
IO min postocclusion 0.07 t 0.03 0.10 t 0.04 0.24 t 0.05 
25 min postreperlusion (“stunned”) 0.69 + 0.16 0.78 +- 0.16 0.98 + 0.24 p = NS 
60 min posttreatment 0.65 t 0.09 0.71 + 0.10 0.87 t 0.1 I 
Normally perfused circumflex bed 
IO min postocclusion 
25 min postreperfusion I”stunned”) 
60 min posttreatment 
Abbreviations as in Table 2. 
1.00 If- 0.10 0.89 + 0.09 0.79 + 0.10 
0.96 t 0.28 0.86 +- 0.24 0.77 + 0.21 p = NS 
0.89 i 0.14 0.77 i 0.1 I 0.75 + 0.14 
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Figure 2. Segment shortening in the ischemic left anterior descend- 
ing artery bed expressed as a percent of preocclusion values (% of 
PRE) for dogs that received intracoronary nifedipine. *p < 0.03 
versus 25 min after reperfusion. Posttreat = after treatment. 
responses (12,14,15), and previous evidence has suggested 
that the stunned myocardium may be sensitive to both 
reductions in afterload (23) and increases in regional myo- 
cardial blood flow (23). Thus, the improvement in systolic 
contractile function observed with intravenous nifedi- 
pine could have been due to reflex activation, to the con- 
comitant and nonspecific reduction in afterload or to the 
increase in regional myocardial blood flow observed after 
treatment. 
To address this issue, we infused minute doses of nifedi- 
pine directly into the stunned, previously ischemic left 
anterior descending coronary artery bed. In contrast to the 
intravenous protocol, intracoronary infusions of nifedipine 
in these very small doses did not alter mean aterial pressure 
(or any other measured hemodynamic variable) and did not 
elicit a hyperemic response in the previously ischemic 
tissue. We did, however, find that the regional contractile 
function of the stunned myocardium was improved signifi- 
cantly in the absence of any measured hemodynamic or 
vasodilator response. The reduction in mean arterial pres- 
sure and increase in regional myocardial blood flow ob- 
served in the intravenous protocol could have partially 
mediated the observed improvement in function (that is, 
segment shortening was restored to a full 100% of normal 
baseline values in the intravenous protocol versus 75 to 90% 
of preocclusion values in the intracoronary protocol). How- 
ever, results from the intracoronary phase of the study 
suggest that nifedipine may exert a direct beneficial effect on 
the stunned myocytes. 
Role of altered calcium flux in the pathogenesis of the 
“stunned” myocardium. Recent evidence obtained from a 
variety of experimental models and techniques (7-11) indi- 
cates that the stunned myocardium may be a consequence of 
abnormal calcium flux during occlusion or at the time of 
reperfusion. Weiss et al. (1 I), who quantified diastolic myo- 
filament motion due to sarcoplasmic reticulum-myofilament 
calcium cycling in isolated perfused rat hearts, found that 
increasing the calcium content of the perfusate increased 
calcium cycling-and decreased recovery of postischemic 
function-after transient global ischemia. Using isolated 
perfused ferret hearts, Kitakaze et al. (9) noted that a brief 
period of transient global ischemia significantly elevated 
levels of free cytosolic calcium during both the final minutes 
of ischemia and the initial 10 min of reflow. Furthermore, 
Kitakaze et al. (10) were able to simulate postischemic 
dysfunction characteristic of stunned myocardium in the 
absence of ischemia by perfusing isolated ferret hearts with 
high concentrations of calcium. Additional supportive evi- 
dence has also been obtained from an in vivo model of 
transient coronary occlusion, in which Krause et al. (8) 
found that calcium transport during relaxation was impaired 
in previously ischemic canine myocardium. Because the 
calcium content or flux of stunned myocardium appears to 
be abnormal, it is possible that nifedipine may attenuate 
postischemic dysfunction by favorably modulating calcium 
homeostasis within the stunned, previously ischemic 
myocytes. 
Other data from our laboratory (5) and others (24,25) 
indicate that the stunned myocardium may be due in part to 
the cytotoxic action of oxygen-derived free radicals gener- 
ated during occlusion or at the time of reflow. In fact, the 
production of oxygen free radicals may be mediated by a 
calcium-regulated protease (2628). Thus, the enhanced re- 
covery of postischemic contractile function observed both 
with free radical scavenging agents (5,24,25) and calcium 
channel blocking agents may share a common mechanism of 
action. This hypothesis, however, remains to be substanti- 
ated. 
Summary and clinical implications. Results of the present 
study indicate that the calcium channel blocking agent 
nifedipine, given 30 min after reperfusion, restored systolic 
contractile function of postischemic stunned myocardium to 
essentially normal preocclusion values. These improve- 
ments in function were not dependent on the reduction in 
mean arterial pressure or increase in regional myocardial 
blood flow associated with intravenous infusion of nifedipine 
because minute doses of nifedipine infused directly into 
previously ischemic myocardium produced similar signifi- 
cant beneficial effects in the absence of systemic hemody- 
namic or hyperemic effects. Thus, we conclude that “de- 
layed” treatment with nifedipine may improve systolic 
contractile function of previously ischemic myocardium by 
favorably modulating calcium flux within the stunned 
myocytes. Although any clinical extrapolation of these data 
must be made with caution, our results raise the possibility 
that nifedipine administered after reperfusion may also at- 
tenuate contractile dysfunction in clinical instances of post- 
ischemic stunned myocardium. 
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